Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures.
Ding Z, Wu H, Zeng Y, Kuang M, Yang W, Meng Z, Chen Y, Hao C, Zou S, Sun H, Liu C, Lin K, Shi G, Wang X, Fu X, Chen R, Chen Y, Liang R, Kano T, Pan H, Yang S, Fan J, Zhou J. Ding Z, et al. Among authors: lin k. Hepatol Int. 2023 Feb;17(1):180-189. doi: 10.1007/s12072-022-10421-9. Epub 2022 Oct 18. Hepatol Int. 2023. PMID: 36258065 Free PMC article. Clinical Trial.
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients.
Lin KY, Lin ZW, Chen QJ, Luo LP, Zhang JX, Chen JH, Wang K, Tai S, Zhang ZB, Wang SF, Zhang JY, You WY, Wang B, You PH, Lin KC, Yang T, Zeng YY. Lin KY, et al. Among authors: lin kc, lin zw. Hepatol Int. 2023 Dec;17(6):1477-1489. doi: 10.1007/s12072-023-10561-6. Epub 2023 Jun 29. Hepatol Int. 2023. PMID: 37382760
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study.
Chen QJ, Lin KY, Lin ZW, Zhang B, Liu MQ, Zhang JX, Huang QZ, Lin KC, Zhang JY, Wei FQ, You PH, You S, Jiang YB, Zhang H, Cheng ZQ, Wang CR, Zeng YY. Chen QJ, et al. Int Immunopharmacol. 2023 Dec;125(Pt A):111098. doi: 10.1016/j.intimp.2023.111098. Epub 2023 Nov 3. Int Immunopharmacol. 2023. PMID: 37925946
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study.
Lin KY, Zhang JX, Lin ZW, Chen QJ, Luo LP, Chen JH, Wang K, Tai S, Zhang ZB, Wang SF, Li JD, Wang K, Zheng L, Zheng SM, Wu MM, Lin KC, Yang T, Zeng YY. Lin KY, et al. Among authors: lin kc, lin zw. Front Immunol. 2024 Feb 16;15:1308543. doi: 10.3389/fimmu.2024.1308543. eCollection 2024. Front Immunol. 2024. PMID: 38433845 Free PMC article.
10,389 results
You have reached the last available page of results. Please see the User Guide for more information.